Frank Svoboda Sells 12,500 Shares of Globe Life (NYSE:GL) Stock

Globe Life Inc. (NYSE:GL) CEO Frank Svoboda sold 12,500 shares of Globe Life stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $144.78, for a total transaction of $1,809,750.00. Following the sale, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at $5,192,969.04. This represents a 25.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Globe Life Trading Up 0.2%

NYSE GL opened at $143.94 on Friday. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. The stock’s 50-day simple moving average is $141.33 and its two-hundred day simple moving average is $138.56. Globe Life Inc. has a twelve month low of $109.38 and a twelve month high of $152.71. The company has a market capitalization of $11.46 billion, a price-to-earnings ratio of 10.22 and a beta of 0.47.

Globe Life (NYSE:GL) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The firm had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.53 billion. Globe Life had a return on equity of 21.75% and a net margin of 19.37%.Globe Life’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Research analysts forecast that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Hedge Funds Weigh In On Globe Life

Several hedge funds have recently made changes to their positions in the business. Mather Group LLC. bought a new stake in Globe Life in the third quarter valued at $28,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Globe Life in the 4th quarter worth about $30,000. CYBER HORNET ETFs LLC purchased a new stake in shares of Globe Life in the 2nd quarter worth about $28,000. Assetmark Inc. boosted its stake in shares of Globe Life by 777.8% during the 2nd quarter. Assetmark Inc. now owns 237 shares of the company’s stock valued at $29,000 after purchasing an additional 210 shares in the last quarter. Finally, MUFG Securities EMEA plc purchased a new position in shares of Globe Life during the second quarter valued at about $31,000. 81.61% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on GL shares. Weiss Ratings upgraded shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a report on Friday, February 13th. TD Cowen reissued a “buy” rating on shares of Globe Life in a research note on Thursday, December 11th. Wells Fargo & Company reduced their price objective on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Evercore set a $157.00 target price on Globe Life in a research note on Wednesday. Finally, Piper Sandler restated an “overweight” rating and set a $167.00 price target on shares of Globe Life in a research report on Friday, November 21st. Eight investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $171.22.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.